Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Accounts Payable
Yield10 Bioscience Inc
Accounts Payable Peer Comparison
Competitive Accounts Payable Analysis
Latest Figures & CAGR of Competitors
Company | Accounts Payable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Accounts Payable
$1.2m
|
CAGR 3-Years
129%
|
CAGR 5-Years
64%
|
CAGR 10-Years
7%
|
|
Abbvie Inc
NYSE:ABBV
|
Accounts Payable
$30.7B
|
CAGR 3-Years
15%
|
CAGR 5-Years
21%
|
CAGR 10-Years
17%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Accounts Payable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Accounts Payable
$1.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Accounts Payable
$3.4B
|
CAGR 3-Years
180%
|
CAGR 5-Years
98%
|
CAGR 10-Years
53%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Accounts Payable
$671.3m
|
CAGR 3-Years
7%
|
CAGR 5-Years
23%
|
CAGR 10-Years
35%
|
See Also
What is Yield10 Bioscience Inc's Accounts Payable?
Accounts Payable
1.2m
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Accounts Payable amounts to 1.2m USD.
What is Yield10 Bioscience Inc's Accounts Payable growth rate?
Accounts Payable CAGR 10Y
7%
Over the last year, the Accounts Payable growth was 1 102%. The average annual Accounts Payable growth rates for Yield10 Bioscience Inc have been 129% over the past three years , 64% over the past five years , and 7% over the past ten years .